Shanghai, China

Chunxiang Kuang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Fudan University. Active years: 2018.


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Chunxiang Kuang

Introduction

Chunxiang Kuang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds with potential therapeutic applications. His work is characterized by a focus on innovative methods and high-yield production processes.

Latest Patents

Chunxiang Kuang holds a patent for an invention titled "N-benzyl tryptanthrin derivative, and preparation method and application thereof." This invention relates to a specific derivative that exhibits good indoleamine-2,3-dioxygenase (IDO) inhibitory activity. The preparation method is noted for its simplicity, mild conditions, and high yield, making it suitable for industrial production. The N-benzyl tryptanthrin derivative can be utilized in treating diseases associated with IDO-mediated tryptophan metabolism.

Career Highlights

Chunxiang Kuang is affiliated with Fudan University, where he engages in research and development activities. His academic background and research endeavors have positioned him as a key figure in his field. He has successfully navigated the complexities of patent applications, ensuring that his innovations are protected and recognized.

Collaborations

Chunxiang Kuang collaborates with Qing Yang, who is also involved in research activities at Fudan University. Their partnership exemplifies the collaborative spirit of scientific inquiry and innovation.

Conclusion

Chunxiang Kuang's contributions to the field of chemistry, particularly through his patented innovations, highlight the importance of research in developing new therapeutic agents. His work not only advances scientific knowledge but also has the potential to impact healthcare positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…